Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia.

MLA

Sütő, Renáta, et al. “Elevated Level of Serum Human Epididymis Protein 4 (HE4) Predicts Disease Severity and Mortality in COVID-19 Pneumonia.” BMC Pulmonary Medicine, vol. 23, no. 1, Dec. 2023, p. 512. EBSCOhost, https://doi.org/10.1186/s12890-023-02811-y.

APA

Sütő, R., Pócsi, M., Szabó, Z., Fejes, Z., Ivády, G., Kerekes, G., Fagyas, M., Nagy, A., Szentkereszty, Z., Kappelmayer, J., & Nagy, B., Jr. (2023). Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia. BMC Pulmonary Medicine, 23(1), 512. https://doi.org/10.1186/s12890-023-02811-y

Chicago

Sütő, Renáta, Marianna Pócsi, Zsolt Szabó, Zsolt Fejes, Gergely Ivády, György Kerekes, Miklós Fagyas, et al. 2023. “Elevated Level of Serum Human Epididymis Protein 4 (HE4) Predicts Disease Severity and Mortality in COVID-19 Pneumonia.” BMC Pulmonary Medicine 23 (1): 512. doi:10.1186/s12890-023-02811-y.